Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Accounts Payables (2020 - 2025)

Biofrontera (BFRI) has 6 years of Accounts Payables data on record, last reported at $6.6 million in Q3 2025.

  • For Q3 2025, Accounts Payables rose 40.77% year-over-year to $6.6 million; the TTM value through Sep 2025 reached $6.6 million, up 40.77%, while the annual FY2024 figure was $4.3 million, 4.77% down from the prior year.
  • Accounts Payables reached $6.6 million in Q3 2025 per BFRI's latest filing, up from $5.8 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $11.1 million in Q1 2023 and bottomed at $269000.0 in Q1 2022.
  • Average Accounts Payables over 5 years is $6.2 million, with a median of $5.2 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: crashed 89.58% in 2021, then soared 4039.41% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $282000.0 in 2021, then surged by 3752.48% to $10.9 million in 2022, then plummeted by 58.7% to $4.5 million in 2023, then fell by 4.77% to $4.3 million in 2024, then soared by 53.36% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $6.6 million in Q3 2025, $5.8 million in Q2 2025, and $4.6 million in Q1 2025.